200
Participants
Start Date
September 30, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
September 30, 2028
Drug: 4-Aminopyridine
Active study drug
Placebo
Placebo comparator
University of Arizona, Tucson
John Elfar
OTHER